NDRA Stock: ENDRA Life Sciences Inc. Stock Price, Analysis & Insights
Get live ndra stock price $4.30, comprehensive ENDRA Life Sciences Inc. stock analysis, charts, news, and expert forecast. Real-time ndra stock data and investment insights.
Loading chart...
Company Overview
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Company Information
- CEO
- Alexander Y. Tokman
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 21
Contact Information
- Website
- https://www.endrainc.com
- Address
- 3600 Green Court
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 0.2)
✓ Lower volatility stock (Beta: -0.31) may provide portfolio stability
Business Model & Strategy
ENDRA Life Sciences Inc. operates in the Medical - Diagnostics & Research industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Alexander Y. Tokman, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Diagnostics & Research model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
ENDRA Life Sciences Inc. competes in the Medical - Diagnostics & Research within the broader Healthcare. With 3.2 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Capital Market, ENDRA Life Sciences Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating ENDRA Life Sciences Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for ENDRA Life Sciences Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for ENDRA Life Sciences Inc.
- ⚠Investors should consider how ENDRA Life Sciences Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
3.24M
P/E Ratio
0.22
Beta
-0.31
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 3.24M market capitalization
- Trading Volume: 80.71K shares traded today
- Price Range: 52-week range of $2.90 - $11.96
- Exchange: Listed on NASDAQ Capital Market
Financial Metrics
Market Analysis for ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc. (NDRA) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. With a current market capitalization of 3.24M, the company represents a significant player in its market. The stock is currently trading at $4.30 with a negativedaily change of 23.76%.
The company's 21 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 0.22, beta of -0.31, and 52-week price range from $2.90 to $11.96when evaluating investment opportunities.
Why Invest in ENDRA Life Sciences Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Capital Market)
- • Experienced leadership under Alexander Y. Tokman
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.